Jove
Visualize
お問い合わせ
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 医療科学
  4. 流行病学について
  5. 疫学的な方法
  6. 下肢表面性血栓炎の治療
  1. ホーム
  2. 研究分野
  3. 医療科学
  4. 流行病学について
  5. 疫学的な方法
  6. 下肢表面性血栓炎の治療

関連する実験動画

Grade III Varicocele Surgical Treatment using Spermatic Vein-Superficial Abdominal Vein Shunt
05:00

Grade III Varicocele Surgical Treatment using Spermatic Vein-Superficial Abdominal Vein Shunt

Published on: August 23, 2024

2.4K

下肢表面性血栓炎の治療

Marcello Di Nisio1, Iris Wichers2, Saskia Middeldorp1

  • 1Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands.

JAMA
|November 2, 2018

PubMed で要約を見る

まとめ
この要約は機械生成です。

表面性血栓炎 (ST) の患者では,出血が増加することなく,ファンダパリヌックスは症状を伴う静脈性血栓栓症 (VTE) を有意に減少させる. 低分子量ヘパリンとNSAIDsは,ST拡張を防ぐのに役立ちますが,VTEデータは不確実です.

科学分野:

  • 血管医学
  • 薬理学について
  • クリニカル・トランボシス

背景:

  • 表面性血栓炎 (ST) は,表面性静脈の炎症と凝固を伴う状態である.
  • 静脈血栓症 (VTE) は,STの潜在的な合併症である.
  • 静脈動脈炎のリスクを最小限に抑えるための最適の治療戦略は明確化が必要です.

研究 の 目的:

  • 下肢表面性血栓炎 (ST) の治療法を評価する.
  • 様々なST治療とプラセボに関連した静脈性血栓塞栓事件 (VTE) の割合を比較する.

主な方法:

  • ST治療とプラセボを比較したランダム化比較試験の体系的レビューとメタ分析.
  • ファンダパリヌックス,低分子量ヘパリン (LMWH),非ステロイド抗炎症薬 (NSAIDs),および経口リバロキサバンを評価した研究を含む.

主要な成果:

  • プラセボと比較して,症状のあるVTEが少なく,大出血の有意な増加は認められませんでした.
  • 低分子量ヘパリン (LMWH) と非ステロイド性抗炎症薬 (NSAIDs) は,プラセボと比較して,ST延長または再発率が低いことを示した.
  • LMWHとNSAIDが症状性VTEの発生率に及ぼす影響に関する証拠は,まだ定かではありません.

さらに関連する動画

The Superficial Inferior Epigastric Artery Fascia Flap for Nerve Reconstruction in Rabbits
12:01

The Superficial Inferior Epigastric Artery Fascia Flap for Nerve Reconstruction in Rabbits

Published on: June 13, 2025

982
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.2K

関連する実験動画

Grade III Varicocele Surgical Treatment using Spermatic Vein-Superficial Abdominal Vein Shunt
05:00

Grade III Varicocele Surgical Treatment using Spermatic Vein-Superficial Abdominal Vein Shunt

Published on: August 23, 2024

2.4K
The Superficial Inferior Epigastric Artery Fascia Flap for Nerve Reconstruction in Rabbits
12:01

The Superficial Inferior Epigastric Artery Fascia Flap for Nerve Reconstruction in Rabbits

Published on: June 13, 2025

982
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

16.2K

関連する概念動画

Absolute and Local Extreme Values01:22

Absolute and Local Extreme Values

74
The highest and lowest values of a function, relative to a reference axis, are known as extreme values. These include absolute maximum and absolute minimum values, which represent the highest and lowest points the function reaches across its entire domain. Within a restricted portion of the function, the highest and lowest values are referred to as local maximum and local minimum values, respectively.Periodic functions, such as sine and cosine, show extreme values at infinitely many points due...
74
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

997
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
997
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

952
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
952
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  • 経口リバロキサバンは,ST管理における有効性と安全性に関するさらなる調査を必要としています.
  • 結論:

    • 表面性血栓炎におけるVTEを減少させるのに有効な治療法として,フォンダパリヌックスは登場しています.
    • LMWHとNSAIDは局所的なST進行に有益ですが,VTEリスク評価にはより多くのデータが必要です.
    • リバロキサバのような経口抗凝固剤は,STの管理においてさらなる研究が必要である.